INTRODUCTION
The v-Src oncoprotein transforms fibroblasts in culture and can stimulate quiescent rat and chicken fibroblasts to reenter cell cycle (Bell et al., 1975; Durkin and Whitfield, 1984; Welham et al., 1990; Catling et al., 1993) . Recent evidence implies that v-Src initiates events at the cell periphery, primarily signaling protein interactions mediated by the Src homology (SH)-2 and SH3 domains (reviewed in Pawson and Schlessinger, 1993 ) and protein tyrosine phosphorylations, which in turn activate intracellular effector systems and give rise to altered gene expression in the nucleus. Although many parallels have been drawn between growth factor receptor-and v-Src-mediated signaling and putative mediators identified, the pathways by which v-Src transforms cells still remain to be elucidated. In particular, the specific events that distinguish the oncogenic stimulus provided by v-Src from the growth stimulus of growth factors are not well understood.
Key transcription factors are involved in coupling signals at the cell periphery to gene expression in the nucleus by binding to specific DNA target sequences in the promoters of responsive genes. AP-1 is one transcription factor involved in the conversion of signals provided by activated growth factor receptors, oncogenes, and protein kinase C into the altered gene expression that underlies the biological consequences of these stimuli. AP-1 is dimeric, comprising members of the Jun and Fos families. The first nuclear response to growth factor-induced mitogenic signaling is rapid induction of the "immediate-early" class of genes, which includes c-fos and c-jun, whose stimulation is important for exit from Go and cell-cycle progression.
In addition to transcriptional stimulation, AP-1 DNA binding and transactivation activities can also be regulated by posttranslational mechanisms in response to biological stimuli, including oncogenic Src, Ras, and Raf (Abate et al., 1990; Binetruy et al., 1991; Boyle et al., 1991; Frame et al., 1991; Lin et al., 1992; Pulverer et al., 1991; Smeal et al., 1991; Derijard et al., 1994; Kyriakis et al., 1994) . We have previously examined the early regulation of AP-1 in resting CEF that are induced to reenter cycle and transform upon activation of temperature sensitive (ts) v-Src (Catling et al., 1993) . DNA binding and transactivation are stimulated soon after shift to permissive temperature, effects are mediated partly by enhanced transcription of c-fos and altered phosphorylation of c-Jun. A nonmyristylated ts v-Src protein does not stimulate AP-1 activity, is transformation-defective, and is unable to induce CEF to reenter cycle, implying that crucial signaling events at the membrane are required for the early increase in AP-1 activity that accompanies v-Src-induced mitogenesis and transformation. In rat fibroblasts AP-1 activity is also enhanced in response to activation of v-Src, although this is not mediated by increased synthesis of c-fos or c-jun transcripts (Welham et al., 1990) . Thus, stimulation of AP-1 correlates with v-Src activity in a number of settings, although achieved by different mechanisms, implying an important role for AP-1 regulated genes in the biological consequences of v-Src.
Dimerization of the components of AP-1 is mediated by the leucine repeats of Jun and Fos and is essential for DNA binding. Fos does not homodimerize and so does not bind to DNA independently of Jun, whereas Jun is able to form homodimers and heterodimers with Fos, the latter having greater stability and higher affinity for the specific DNA recognition sequence (reviewed in Gillespie, 1991) . These properties of AP-1 have allowed the design of inhibitory mutants of Fos and Jun that are able to dimerize with their cellular partners but form nonfunctional complexes because of their inability to bind to DNA and lack of sequences normally associated with transactivation function. Such mutants have been used to demonstrate a role for AP-1 in transformation of chick embryo fibroblasts (CEF) by c-jun (Okuno et al., 1991) and transformation of rat embryo cells by activated ras and deregulated c-jun and c-fos genes (Brown et al., 1993) .
In this present study we have examined the effects of expressing a mutated Fos protein on the mitogenic and morphological activities of v-Src. We conclude that AP-1 stimulation is required for mitogenesis but not the ultrastructural changes that give rise to the morphological appearance of v-Src-transformed cells. This implicates AP-1 as a nuclear target for the mitogenic pathway but not the cytoskeletal/morphological pathway initiated by v-Src and shows that these two pathways are, at least in part, biochemically separable.
MATERIALS AND METHODS

Cloning and Expression of c-fos Mutant with ts v-Src in CEF
The replication competent avian retrovirus (RCAN) expressing the ts mutant of v-Src, LA 29, was constructed as described previously (Catling et al., 1993) . Standard polymerase chain reaction (PCR) technology was used to obtain the basic and leucine zipper coding sequences of murine c-fos (amino acids 111-206) containing four codons that give rise to insertion of the amino acid sequence PLER (in the single letter amino acid code) at amino acid 161 in the murine c-Fos sequence. A Kozak consensus was incorporated into the 5' primer to ensure efficient transcription initiation. HindIII and BamHI sites were included in the 5' and 3' primers, respectively, to allow ligation with a BamHI/Eco Rl fragment encoding the HE14 portion of the human estrogen receptor (ER) and the pSFCV-LE-Sa+ vector (Fuerstenberg et al., 1990 ) cut with HindIII and EcoRI ( Figure 1A ). The cloned PCR product was confirmed by sequencing. Plasmids used in cell transfection experiments were purified through caesium chloride gradients. Sequences encoding the HE14 portion of the human ER (Kumar et al., 1986) , preceded by an initiating methionine codon, were also cloned into pSFCV as control.
Primary CEF cultures were grown and cotransfected at low density with RCAN-Src construct (5-10 Mg per 25-cm2 flask) and pSFCV6Fosi-ER fusion construct (10 jig per 25-cm2 flask) at restrictive temperature (41°C) using the calcium phosphate method. Growth and transfection were as described in Crouch et al., 1990 with the addition of 1 AM f-oestradiol. Transfected cultures were selected in G418 and found to uniformly express v-Src and the ER fusion proteins by immunoblotting using anti-Src monoclonal EC10 (Tissue Culture Services, UK) and the anti-ER monoclonal (F3-A) (Euromedex, Schiltighein, France) ( Figure 1B ).
Electrophoretic Mobility Shift Assay (EMSA)
Total cell protein extracts were prepared as described in Marais et al. (1993) . Briefly, whole cell extracts were prepared from 90-mm dishes of cells. The cells were washed twice with phosphate-buffered saline (PBS) and lysed with 50 Ml extract buffer. Extracts were sonicated and clarified by high speed centrifugation; protein concentration of supernatants was determined by the Bio-Rad Laboratories (Richmond, CA) protein assay kit and stored at -70°C. Ten micrograms of cell extract was incubated for 30 min on ice with a radiolabeled oligonucleotide containing the AP-1 consensus from the collagenase promoter. Incubation buffers and acrylamide gels were as described in Frame et al. (1991) . Similar results to those found with AP-1 DNA binding activities from whole cell extracts were obtained using proteins extracted from purified nuclei (unpublished observations).
Mitogenesis
Low density cultures were made quiescent at restrictive temperature by incubating in 0.2% serum for 48-72 h. DNA synthesis was measured at various times after stimulation by pulse labeling with tritiated methylthymidine (Amersham, Arlington Heights, IL) as described previously (Welham et al., 1990 Proteins resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) were transferred to nitrocellulose using a semidry blot procedure. After appropriate blocking (3% Marvel or 3% bovine serum albumin for anti-phosphotyrosine blots with 0.2% Tween 20 [Sigma, St. Louis, MO] ) overnight at 4°C, blots were incubated with the primary antisera, washed extensively with PBS/ 0.2% Tween 20, and incubated with 1:5000 horse radish peroxidaseconjugated anti-mouse or anti-rabbit serum (Amersham). Reactive Molecular Biology of the Cell proteins were visualised using enhanced chemiluminesence according to the manufacturer's instructions (Amersham). Primary antisera were used at the following concentrations: anti-Src EC10, 1:5000; anti-ER, 1:1000; anti-phosphotyrosine (Upstate Biotechnology, Lake Placid, NY), 1:5000.
CEF protein lysates for immunoprecipitation were prepared in RIPA buffer (Black et al., 1991) as described previously (Catling et al., 1993 
Cloning and Expression of the c-fos Mutant
We have used an approach similar to that of other groups to inhibit AP-1 by expression of an interfering mutant of c-Fos. The mutant was designed to bind to its cellular partners from the Jun family of proteins but form dimers that could not bind to the AP-1 recognition sequence. We made use of the published, observations that the leucine zipper and DNA binding domains were sufficient to specify dimerization and DNA contact in the absence of the rest of the proteins (Abate et al., 1990 ). Thus, a region of c-fos encoding the entire leucine zipper and basic DNA binding domain, which contained a four amino acid helix disrupting insertion between the basic region and leucine zipper, was cloned into SFCV (5Fosi) (described in MATERIALS AND METH-ODS). Insertion of codons for the same four amino acids into c-fos coding sequences has been shown to disrupt Fos function and inhibit cellular AP-1 in a dominant manner (Yoshida et al., 1989 , Okuno et al., 1991 . The c-fos sequences were fused to the HE14 portion of the human ER ( Figure 1A ), providing an epitope tag. As control, the HE14 domain preceded by an initiating methionine codon was also introduced into SFCV (mER) ( Figure 1A ). These constructs were cotransfected into CEF with the replication competent retroviral vector RCAN encoding the ts v-Src mutant LA29. After selection with G418, the cell lysates were probed with Srcand ER-specific antibodies. As expected, the cells were uniformly infected with the v-Src-expressing retrovirus ( Figure 1B , lanes 6 and 7). Cells transfected with the 6Fosi-ER and mER constructs expressed proteins of the expected molecular weights that reacted with the ER antibody ( Figure 1B , lanes 2 and 3, respectively). Cells transfected with 5Fosi-ER also consistently produced proteins with lower apparent molecular weights, perhaps indicating cleavage within the cell ( Figure 1B, (Figure 2 , lane 2), although there always remained appreciable AP-1 DNA-binding activity. The specificity of the AP-1 DNA-binding complex was confirmed by inhibition with unlabeled competitor (Figure   2, lanes 3 and 4) . Thus, expression of 6Fosi-ER resulted in a partial inhibition of cellular AP-1 activity in growing CEF that had no obvious effect on cell growth. We next examined the ability of activation of ts v-Src to stimulate AP-1 DNA binding in CEF expressing mER and 6Fos8-ER and made quiescent by serum deprivation.
The mER control cells responded to a shift to permissive temperature by stimulation of AP-1 DNA binding, seen 1 h after temperature shift ( Figure 3, lanes 2-4) , an effect that we previously found to occur only in response to biologically active mutants of v-Src (Catling et al., 1993 born calf serum (5%) ( Figure 4C ). During the course of the experiment, the levels of thymidine uptake for both transfectants remained low and invariant in the absence of any stimulus ( Figure 4A ). In the mER control cells, activation of v-Src and serum addition resulted in entry into S-phase as measured by uptake of tritiated thy- is itself activated by tyrosine phosphorylat plicated in mediating the cytoskeletal chang( rise to the morphological appearance of tr cells (Schaller et al., 1992 for 24 h, FAK appeared to undergo a gel mobility shift to an apparently higher molecular weight (Figure 6 , lane 3), presumably as a result of hyperphosphorylation and/or a conformational change. These observations are in agreement with previous reports that increased x mER phosphorylation of p125 is characterized by a shift in * WFos,ER gel mobility in cells transformed by activated variants of c-src and v-src (Kanner et al., 1990; Seidel-Dugan et al., 1992) . We are not able to conclude whether the total phosphotyrosine content of p125 was increased in rex mER sponse to activation of v-Src in these experiments because the immunoblots were not titrated. In CEF transfected with bFosi-ER, the change in gel mobility of FAK in response to activation of v-Src was similar to the mER control ( Figure 6 , lanes 4 and 5), indicating that the posttranslational alteration of FAK that gives rise to the change in migration on SDS-PAGE does not require * WFos.ER the early stimulation in AP-1 activity that normally accompanies v-Src activation.
DISCUSSION
In this study we have used a mutant of c-fos encoding a protein that interferes with the normal regulation of the cellular transcription factor AP-1 to examine the x mER need for AP-1 in v-Src-induced mitogenesis and morphological transformation. Stable expression of the cFos leucine zipper and disrupted basic region, fused to the HE14 portion of the human ER, substantially reduced the early v-Src-induced stimulation of AP-1 in * oFosjER cells made quiescent by serum deprivation but not in cells growing exponentially. This AP-1 reduction was accompanied by a marked impairment of v-Src-driven exit of quiescent cells from Go.
These observations parallel closely those of Nishikura .nidin upte and Murray (1987) , who showed that NIH3T3 cells exhadneadpbekn pressing antisense fos cycled almost normally in exponperature and nential growth but were unable to leave Go and reenter )L), shifted to cycle in response to platelet-derived growth factor. An provided with antisense approach has also demonstrated a need for AP-1 in the mitogenic response of target cells to tumour necrosis factor-a (Brach et al., 1993) . These observations, with ours, indicate that AP-1 stimulation is a general tion, is im-prerequisite for the transition from Go to Gl, although es that give this early AP-1 activation is not sufficient for cells to ransformed enter S-phase in the absence of other factors, because Led tyrosine there is a second requirement for v-Src activity in mid-) activation G, . iitory 6Fosi-We also found that in CEF transfected with dominant d from cell negative Fos the morphological changes characteristic -PAGE and of v-Src transformation were unimpaired, showing that antibodies. AP-1 activation is a specific and necessary nuclear conmER at resequence of v-Src activity that is dispensable for mor-)sine phos-phological transformation. This finding is ostensibly at that in cells variance with the conclusions of some previous work. ) (Figure 6 , Expression of antisense fos RNA partially inhibits rasemperature induced transformation (Ledwith et al., 1990 ), yet an- tibodies to p21 Ras inhibit v-Src transformation (Smith et al., 1986) , implying that Ras function is needed for v-Src to transform cells. In addition, several groups (Kouzarides and Ziff, 1988; Gentz et al., 1989; Okuno et al., 1989; Ransone et al., 1990; Smeal et al., 1989; Turner and Tjian, 1989) have reported derivatives of both c-Fos and c-Jun that act as transdominant inhibitors of AP-1 of the kind that have been shown to suppress oncogene-induced transformation. In particular, a c-jun dominant negative mutant suppressed transformation of rat embryo cells induced by oncogenic ras or deregulated c-jun or c-fos (Brown et al., 1993) . This is consistent with other reports of Jun and Fos proteins interfering with ras transformation (Lloyd et al., 1991; Wick et al., 1992) , although in the latter case the inhibition may have been by mechanisms other than direct reduction in AP-1-dependent transactivation. The consensus that v-Src requires Ras activity and that the latter acts through AP-1 can only be partially reconciled with our finding that AP-1 is dispensable for v-Src transformation by postulating that Ras mediates aspects of v-Src activity independently of AP-1. These AP-1-independent activities must be insufficient for Ras transformation but adequate for transformation by v-Src, possibly because v-Src has other Ras-and AP-1-independent effects. Our conclusion that v-Src-induced mitogenesis and transformation are at least partly separable, although not predicted by the findings discussed above, are, in fact, supported by several earlier observations. Nonmyristylated v-Src mutants were nontransforming but promoted proliferation of neuroretinal cells (Calothy et al., 1987) , although the same mutants were nonmitogenic for quiescent CEF as used in this study (Catling et al., 1993) . In addition, some ts mutants dissociated morphological changes from growth-related parameters such as cell density and serum-and anchorage-independent multiplication (Weber and Friis, 1979) . The correlates of mitogenesis used in these studies were, however, relatively poorly understood and cannot be readily equated with the transit out of Go that we have examined. Closer parallels for our findings were the observations of Beug et al. (1978) , who reported that ts v-Src mutants can transform enucleated cells, and several studies showing that transformation by ts mutants occurred when de novo transcription was suppressed by Actinomycin D (Kawai and Hanafusa, 1971; Bader, 1972; Biquard and Vigier, 1972) . Such work clearly showed that nuclear functions are not required for some effects of v-Src at the cell periphery, but the indiscriminate ablation of nuclear activity precludes both the prolonged observation and further dissection of the phenomenon that are permitted by our approach.
Our play an important role in the ultrastructural changes that occur at the G2-M transition during the cell cycle, when c-Src is active, and in response to the v-Srctransforming protein (reviewed in Zachary and Rozengurt, 1992; Schaller and Parsons, 1993) . p125 FAK is a cytoplasmic target for oncogenically active forms of Src that result in elevated FAK tyrosine phosphorylation and activity (Kanner et al., 1990) . A complex between FAK and Src, both members of the nonreceptor class of protein tyrosine kinases, is mediated by the Src SH2 domain and the major site of autophosphorylation in FAK (Schaller et al., 1994) . Activation of FAK and/ or translocation of active Src to focal adhesions may lead to enhanced tyrosine phosphorylation of other components of focal adhesions, for example, vinculin and paxillin, both known to exhibit increased tyrosine phosphorylation in v-Src-transformed cells (Sefton et al., 1981; Glenney and Zokas, 1989) . The lack of effect of AP-1 inhibition on the v-Src-mediated effects on FAK implies that its hyperphosphorylation, and presumed activation, is independent of this early nuclear consequence of v-Src activity. However, it is not yet known whether FAK itself provides a signal that is transmitted to the nucleus and alters expression of genes involved in uncontrolled growth or other tumor-associated properties, such as invasion or angiogenesis. It seems likely that, although v-Src mitogenic and morphological effects are partially separate in vitro, full transformation in vivo will need cell growth and hence the activation of both pathways. These concepts are in keeping with a recent detailed study by Miao and Curran (1994) on the kinetics of transformation by c-fos that indicated that, although AP-1 function may contribute to the transforming activities of src, c-Fos alone cannot be fully responsible for all aspects of the transformed phenotype. The ability to ablate specific nuclear consequences of v-Src activity will permit dissection of the interplay between this oncoprotein's mitogenic and morphological transforming properties.
